Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT00519077 · COMPLETED

Trial details

NCT number: NCT00519077
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2005-03-01
Primary completion: 2008-05-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.